Skip to content

Drug interactions

Elagolix + Flibanserin

Severity: Minor

Elagolix and Flibanserin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Elagolix weakly inhibits CYP2C19 and induces CYP3A4, so flibanserin exposure could shift in either direction. The overall clinical effect is uncertain and probably modest.

What this interaction means in plain words

Elagolix and Flibanserin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Elagolix belongs to Musculoskeletal; Flibanserin belongs to Genitourinary.

Evidence level: Low

Why it happens

Opposing effects on flibanserin metabolism via CYP2C19 inhibition and CYP3A4 induction.

What to do

Monitor for changes in flibanserin efficacy or adverse effects such as dizziness and sedation; no preemptive dose change is needed.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Elagolix and Flibanserin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Elagolix with Flibanserin?

MediHelp rates the interaction as minor. Elagolix and Flibanserin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Elagolix weakly inhibits CYP2C19 and induces CYP3A4, so flibanserin exposure could shift in either direction. The overall clinical effect is uncertain and probably modest.

How serious is the interaction between Elagolix and Flibanserin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for changes in flibanserin efficacy or adverse effects such as dizziness and sedation; no preemptive dose change is needed.

What other medicines interact with Flibanserin?

MediHelp also lists interactions of Flibanserin with, for example, Atazanavir, Ceritinib, Clarithromycin. The full list is on the Flibanserin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in